Literature DB >> 11014691

Peritoneal sclerosis: one or two nosological entities?

G Garosi1, N Di Paolo.   

Abstract

The frequency, pathology, animal models, pathogenesis, clinical manifestations, diagnostic criteria, therapy and prevention of peritoneal sclerosis are reviewed. Many of these aspects have a bimodal configuration which suggests that peritoneal sclerosis, usually considered a single pathology in peritoneal dialysis, is actually two distinct nosological entities: simple sclerosis and sclerosing peritonitis. The former is very frequent, with minor anatomical alterations and low clinical impact; it is reproducible in animals by means of peritoneal dialysis, and is clearly due to the poor biocompatibility of peritoneal dialysis solutions. The latter is rare, with radical anatomical alterations and high mortality requiring valid methods of diagnosis, therapy and prevention; it can only be reproduced in animal models by means other than peritoneal dialysis and seems to be due to factors both related and unrelated to peritoneal dialysis.

Entities:  

Mesh:

Year:  2000        PMID: 11014691     DOI: 10.1046/j.1525-139x.2000.00080.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  8 in total

1.  The promising future of long-term peritoneal dialysis.

Authors:  Dimitrios Oreopoulos; Elias Thodis; Kosmas I Paraskevas
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

2.  No need for an "expiry date" in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis.

Authors:  Guido Garosi; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2009-12       Impact factor: 2.370

3.  Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment.

Authors:  Ryo Yamamoto; Yasushi Otsuka; Masaaki Nakayama; Yukio Maruyama; Naohiko Katoh; Masato Ikeda; Hiroyasu Yamamoto; Keitaro Yokoyama; Yoshindo Kawaguchi; Masato Matsushima
Journal:  Clin Exp Nephrol       Date:  2005-06       Impact factor: 2.801

Review 4.  Pathogenesis and treatment of peritoneal membrane failure.

Authors:  Ramesh Saxena
Journal:  Pediatr Nephrol       Date:  2007-09-21       Impact factor: 3.714

5.  Encapsulating peritoneal sclerosis in an Italian center: thirty year experience.

Authors:  Valerio Vizzardi; Massimo Sandrini; Silvia Zecchini; Sara Ravera; Luigi Manili; Giovanni Cancarini
Journal:  J Nephrol       Date:  2015-10-31       Impact factor: 3.902

Review 6.  Protective measures against ultrafiltration failure in peritoneal dialysis patients.

Authors:  Anna Rita Aguirre; Hugo Abensur
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

7.  Acidic organelles mediate TGF-β1-induced cellular fibrosis via (pro)renin receptor and vacuolar ATPase trafficking in human peritoneal mesothelial cells.

Authors:  Ikuko Oba-Yabana; Takefumi Mori; Chika Takahashi; Takuo Hirose; Yusuke Ohsaki; Satoshi Kinugasa; Yoshikazu Muroya; Emiko Sato; Geneviève Nguyen; Rémi Piedagnel; Pierre M Ronco; Kazuhito Totsune; Sadayoshi Ito
Journal:  Sci Rep       Date:  2018-02-08       Impact factor: 4.379

8.  Clinical characteristics of dialysis related sclerosing encapsulating peritonitis: multi-center experience in Korea.

Authors:  Beom Seok Kim; Hoon Young Choi; Dong-Ryeol Ryu; Tae Hyun Yoo; Hyeong Cheon Park; Shin Wook Kang; Kyu Hun Choi; Sung Kyu Ha; Dae Suk Han; Ho Yung Lee
Journal:  Yonsei Med J       Date:  2005-02-28       Impact factor: 2.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.